Geron Corp (NASDAQ:GERN)
| 3.60 Delayed Data As of Jun 02 |  +0.215 / +6.36%Today’s Change | 1.18 Today|||52-Week Range 3.84 | +48.55% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $1.7B |
Company Description
Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies. The firm develops therapeutic products for oncology. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Foster City, CA.
Contact Information
Geron Corp. 919 East Hillsdale Boulevard Foster City California 94404 |
Employees
Shareholders
| Other institutional | 32.20% |
| Individual stakeholders | 2.05% |
| Mutual fund holders | 17.86% |
Top Executives
| John A. Scarlett | Chairman, President & Chief Executive Officer |
| Andrew J. Grethlein | Chief Operating Officer & Executive Vice President |
| Olivia K. Bloom | Chief Financial Officer, Treasurer & Executive VP |
| Faye Feller | Chief Medical Officer & Executive Vice President |
| Stephen N. Rosenfield | Secretary, Chief Legal Officer & Executive VP |
